• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒相关的口咽癌在老年患者中是否变得更常见?

Is HPV-Associated Oropharyngeal Cancer Becoming More Common in Older Patients?

作者信息

Thompson James D, Harari Paul M, Hartig Gregory K

机构信息

Department of Surgery and the Department of Human Oncology University of Wisconsin School of Medicine and Public Health Madison Wisconsin.

出版信息

Laryngoscope Investig Otolaryngol. 2018 Oct 15;3(6):446-449. doi: 10.1002/lio2.181. eCollection 2018 Dec.

DOI:10.1002/lio2.181
PMID:30599028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6302704/
Abstract

OBJECTIVE

To evaluate changing age demographics over a 15-year period for patients with HPV-associated oropharyngeal squamous cell carcinoma (OPSCC).

STUDY DESIGN

Retrospective review of patients identified with p16-positive OPSCC at our institution over a 15-year timeframe. : p16-positive immunohistochemistry was used as a surrogate for HPV-associated OPSCC. Patients were categorized according to year of diagnosis (2002-2010 versus 2011-2016). Mean age and proportion of patients over age 65 were statistically evaluated and compared.

RESULTS

From 2002 to 2010, 100 patients were identified with p16-positive OPSCC, mean age at diagnosis was 55.2, and the proportion of patients over 65 was 10.0%. From 2011 to 2016, 188 patients were identified with p16-positive OPSCC, mean age was 58.5, and the proportion of patients over 65 was 19.6%. Both the mean age difference and the difference in proportion of patients over 65 were statistically significant ( = .001 and  = .034, respectively).

CONCLUSION

The mean age at diagnosis and proportion of patients over 65 has increased over the past 15 years at our institution. This data suggests that HPV-associated OPSCC is being diagnosed more frequently in older persons and that the age demographic may be shifting. Confirmation of this trend with larger patient numbers on a national level will be valuable. This study highlights the importance of maintaining a high clinical suspicion for HPV-associated OPSCC regardless of patient age.

LEVEL OF EVIDENCE

摘要

目的

评估人乳头瘤病毒(HPV)相关的口咽鳞状细胞癌(OPSCC)患者在15年期间年龄分布的变化情况。

研究设计

对我院在15年时间内确诊为p16阳性OPSCC的患者进行回顾性研究。采用p16阳性免疫组化作为HPV相关OPSCC的替代指标。根据诊断年份(2002 - 2010年与2011 - 2016年)对患者进行分类。对平均年龄和65岁以上患者的比例进行统计学评估和比较。

结果

2002年至2010年,确诊为p16阳性OPSCC的患者有100例,诊断时的平均年龄为55.2岁,65岁以上患者的比例为10.0%。2011年至2016年,确诊为p16阳性OPSCC的患者有188例,平均年龄为58.5岁,65岁以上患者的比例为19.6%。平均年龄差异和65岁以上患者比例的差异均具有统计学意义(分别为P = 0.001和P = 0.034)。

结论

在过去15年里,我院诊断时的平均年龄和65岁以上患者的比例有所增加。该数据表明,HPV相关的OPSCC在老年人中诊断更为频繁,年龄分布可能正在发生变化。在全国范围内用更多患者数量证实这一趋势将很有价值。本研究强调了无论患者年龄如何,对HPV相关OPSCC保持高度临床怀疑的重要性。

证据级别

4级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e492/6302704/c9f7425d24c5/LIO2-3-446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e492/6302704/6e85e49b6096/LIO2-3-446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e492/6302704/c9f7425d24c5/LIO2-3-446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e492/6302704/6e85e49b6096/LIO2-3-446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e492/6302704/c9f7425d24c5/LIO2-3-446-g002.jpg

相似文献

1
Is HPV-Associated Oropharyngeal Cancer Becoming More Common in Older Patients?人乳头瘤病毒相关的口咽癌在老年患者中是否变得更常见?
Laryngoscope Investig Otolaryngol. 2018 Oct 15;3(6):446-449. doi: 10.1002/lio2.181. eCollection 2018 Dec.
2
Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.泰国 HPV 相关头颈部鳞状细胞癌患者中 p16 表达的差异:临床特征和生存结局。
BMC Cancer. 2021 May 6;21(1):504. doi: 10.1186/s12885-021-08213-9.
3
Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.新西兰地区癌症中心行调强放疗治疗口咽鳞癌的结果:p16 状态的影响。
Cancer Rep (Hoboken). 2018 Jun;1(1):e1001. doi: 10.1002/cnr2.1001. Epub 2018 Apr 10.
4
Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.口咽鳞状细胞癌:p16/p53 免疫组化作为 HPV 肿瘤状态的强预测因子。
Histopathology. 2021 Sep;79(3):381-390. doi: 10.1111/his.14350. Epub 2021 May 7.
5
The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.生物标志物 p16 在口咽鳞状细胞癌中的预后意义。
Clin Oncol (R Coll Radiol). 2013 Nov;25(11):630-8. doi: 10.1016/j.clon.2013.07.003. Epub 2013 Jul 31.
6
Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.单纯放疗作为人乳头瘤病毒相关局部晚期口咽鳞状细胞癌可能的减量化治疗。
Int J Clin Oncol. 2019 Jun;24(6):640-648. doi: 10.1007/s10147-019-01394-1. Epub 2019 Jan 29.
7
Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.人乳头瘤病毒阳性口咽癌在老年人群中发病率不断上升。
Cancer. 2018 Jul 15;124(14):2993-2999. doi: 10.1002/cncr.31385. Epub 2018 Apr 30.
8
Heterogeneity in the clinical presentation, diagnosis, and treatment initiation of p16-positive oropharyngeal cancer.p16 阳性口咽癌临床表现、诊断和治疗启动的异质性。
Am J Otolaryngol. 2019 Sep-Oct;40(5):626-630. doi: 10.1016/j.amjoto.2019.05.004. Epub 2019 May 14.
9
Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.p16、pRB、cyclin D1 和 p53 等细胞周期相关蛋白在切除的口咽癌中的预后意义。
J Otolaryngol Head Neck Surg. 2018 Sep 6;47(1):53. doi: 10.1186/s40463-018-0298-3.
10
Findings from a Malaysian multicentre study on oropharyngeal squamous cell carcinoma.一项关于口咽鳞状细胞癌的马来西亚多中心研究结果。
Infect Agent Cancer. 2023 Nov 28;18(1):74. doi: 10.1186/s13027-023-00557-0.

引用本文的文献

1
Trends in hospitalization and death rates among patients with head and neck cancer in Spain, 2009 to 2019.西班牙 2009 年至 2019 年头颈部癌症患者住院和死亡率趋势。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2082192. doi: 10.1080/21645515.2022.2082192. Epub 2022 Aug 5.
2
Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.第七版和第八版美国癌症联合委员会(AJCC)分期在选择性和非选择性口咽鳞状细胞癌中的比较。
Oncologist. 2022 Feb 3;27(1):48-56. doi: 10.1093/oncolo/oyab001.
3
Evolving Profile of HPV-Driven Oropharyngeal Squamous Cell Carcinoma in a National Cancer Institute in Italy: A 10-Year Retrospective Study.

本文引用的文献

1
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.E1308:诱导化疗后降低剂量放疗联合西妥昔单抗每周治疗人乳头瘤病毒相关可切除口咽鳞状细胞癌患者的II期试验 - ECOG-ACRIN癌症研究组
J Clin Oncol. 2017 Feb 10;35(5):490-497. doi: 10.1200/JCO.2016.68.3300. Epub 2016 Dec 28.
2
Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.人乳头瘤病毒阳性头颈部鳞状细胞癌的流行病学
J Clin Oncol. 2015 Oct 10;33(29):3235-42. doi: 10.1200/JCO.2015.61.6995. Epub 2015 Sep 8.
3
意大利一家国家癌症研究所中由人乳头瘤病毒驱动的口咽鳞状细胞癌的演变概况:一项10年回顾性研究
Microorganisms. 2020 Sep 29;8(10):1498. doi: 10.3390/microorganisms8101498.
Epidemiology of head and neck cancer.
头颈癌流行病学
Surg Oncol Clin N Am. 2015 Jul;24(3):379-96. doi: 10.1016/j.soc.2015.03.001. Epub 2015 Apr 9.
4
HPV in oropharyngeal cancer: the basics to know in clinical practice.口咽癌中的人乳头瘤病毒:临床实践中需要了解的基础知识。
Acta Otorhinolaryngol Ital. 2014 Oct;34(5):299-309.
5
Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners.口咽癌HPV阳性患者及其伴侣的口腔人乳头瘤病毒(HPV)感染
J Clin Oncol. 2014 Aug 10;32(23):2408-15. doi: 10.1200/JCO.2014.55.1341. Epub 2014 Apr 28.
6
Epidemiology of human papillomavirus-related head and neck cancer.人乳头瘤病毒相关头颈癌的流行病学
Otolaryngol Clin North Am. 2012 Aug;45(4):739-64. doi: 10.1016/j.otc.2012.04.003. Epub 2012 May 31.
7
Human papillomavirus and rising oropharyngeal cancer incidence in the United States.人乳头瘤病毒与美国口咽癌发病率的上升
J Clin Oncol. 2011 Nov 10;29(32):4294-301. doi: 10.1200/JCO.2011.36.4596. Epub 2011 Oct 3.
8
Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study.经口激光微创手术作为中晚期口咽癌的主要治疗方法:一项美国多中心研究。
Head Neck. 2011 Dec;33(12):1683-94. doi: 10.1002/hed.21669. Epub 2011 Jan 31.
9
Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.TROG 02.02 三期临床试验中治疗的口咽癌患者中 p16INK4A 和人乳头瘤病毒的预后意义。
J Clin Oncol. 2010 Sep 20;28(27):4142-8. doi: 10.1200/JCO.2010.29.2904. Epub 2010 Aug 9.
10
Human papillomavirus and survival of patients with oropharyngeal cancer.人乳头瘤病毒与口咽癌患者的生存。
N Engl J Med. 2010 Jul 1;363(1):24-35. doi: 10.1056/NEJMoa0912217. Epub 2010 Jun 7.